Menu
Apply

Thrombocytopenia

Co-Pay Relief Program Fund Notices

Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!

Get Notified


Status
Identified

Approved and Donation Ready

This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.

If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.

Fund Type

Co-pay, Co-Insurance & Deductible

Maximum Award Level

$4,000 Per Year

Eligibility Requirements
  • Household Income Requirements 400 or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
  • Insurance Requirements All Insurance Types
  • Must reside and receive treatment in the United States.

About Thrombocytopenia

Thrombocytopenia is a condition characterized by abnormally low levels of a specific blood cell platelets, in the blood and can be inherited or acquired. The main function of the platelets, or thrombocytes, in the blood, is to help blood clot by forming a plug in the blood vessel, referred to as a thrombus. Although the platelet numbers are decreased, their function remains completely intact. The condition can be caused by decreased platelet production, increased platelet destruction or increased splenic sequestration and may be associated with certain types of cancer, anemia or autoimmune diseases, exposure to toxic chemicals, viral infections, reactions to medications or certain genetic conditions. Treatment depends on its cause and severity, and it can last from days to years. Thrombocytopenia is also called immune or autoimmune thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or thrombotic thrombocytopenic purpura.

Medication & Financial Assistance Resources
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites. PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided. The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.
Apply